The psychiatry and behavioral neurosciences department is dependent on philathropic support. Below is a list of funding priorities.
If you would like to make a gift to any of these funds or would like to explore other giving opportunities, please contact Allen Chapa at (513) 556-6374 or firstname.lastname@example.org or email@example.com
Addiction Disorder Fund
Specifically supports research into Prevention, treatment and education of substance use disorders.
Bipolar Disorder Fund
Specifically supports new treatments for Bipolar Disorder and novel methods to clarify the neurobiology of bipolar disorder. Our ultimate goal is to improve the outcome of children, adolescents and adults with Bipolar Disorder.
Department of Psychiatry Education Fund
The purpose of this fund is to maintain scientific and clinical excellence within the Department of Psychiatry. Funds will specifically support the visiting professors program, provide a research incentive program for our residents and fellows; and to maintain a current library for faculty, residents and fellows.
Post Traumatic Stress Disorder Fund
The goal of the Post Traumatic Stress Disorder Program (PTSD) is twofold: to deliver state of the art treatment to veterans for PTSD and other war-related illness and to develop an empirically derived theory and treatment of PTSD and other war-related illness.
Mood Disorders Fund
Specifically supports the most advanced methods to diagnose and treat adult and adolescent patients with depression, bipolar spectrum disorder, anxiety disorders, cyclothymia and dysthymia.
Schizophrenia Program Fund
The goals of the Schizophrenia Program are to generate new knowledge about the neurobiology and psychopharmacology of schizophrenia and related psychotic disorders. Both animal and human research projects are conducted and new medications with novel mechanisms of action for the treatment of schizophrenia are tested for efficacy and safety. The program also provides education to health professionals and the public and provides clinical consultations to community psychiatrists about treatment-resistant patients with psychosis.